AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35298060 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exercise circulatory occlusion (PECO trial)
Number of subjects: 32
Study 35298060 — intervention group
Group type: COMPARATOR
Intervention: Control trial (rested for four min)
Number of subjects: 32
Study 35298060 — intervention group
Group type: EXPERIMENTAL
Intervention: Handgrip exercise
Number of subjects: 32
Study 32009110 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifal + Arg YG (normal yogurt containing Bifidobacterium animalis ssp. lactis LKM512 and arginine)
Number of subjects: 44
Study 32009110 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifal + Arg YG
Number of subjects: 44
Study 32009110 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal yogurt)
Number of subjects: 44
Study 36333720 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 14
Study 36333720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 33612376 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic artery embolisation (PAE)
Number of subjects: 103
Study 33612376 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 103
Study 32353619 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture Tape (ST)
Number of subjects: 28
Study 32353619 — intervention group
Group type: COMPARATOR
Intervention: High-Strength Suture (HSS)
Number of subjects: 28
Study 33403738 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-concentration carbohydrate solution (300 mL) taken 2 hours before induction of anesthesia
Number of subjects: 85
Study 33403738 — intervention group
Group type: COMPARATOR
Intervention: Warm water (control)
Number of subjects: 85
Study 32585900 — intervention group
Group type: EXPERIMENTAL
Intervention: Stilbenes
Number of subjects: 1874
Study 32585900 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavonoids
Number of subjects: 1874
Study 34448710 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based self-help program (Alcohol e-Health)
Number of subjects: 1400
Study 32186016 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) at Zusanli (ST 36) before and during surgery
Number of subjects: 64
Study 32186016 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 64
Study 32186016 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) at Zusanli (ST 36)
Number of subjects: 64
Study 35120284 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH; 20 mg/d)
Number of subjects: 200
Study 35120284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 33587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Following the evolution of the COVID-19 pandemic in Lebanon
Number of subjects: 386
Study 33587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher compulsion
Number of subjects: 386
Study 33587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a university level of education
Number of subjects: 386
Study 33587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Following the evolution of the COVID-19 pandemic in Lebanon (all of the time, most of the time, sometimes, little of the time)
Number of subjects: 386
Study 33587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher age
Number of subjects: 386
Study 33587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 386
Study 33587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher depression
Number of subjects: 386
Study 33587678 — intervention group
Group type: EXPERIMENTAL
Intervention: Practicing religion some of the time
Number of subjects: 386
Study 35470194 — intervention group
Group type: EXPERIMENTAL
Intervention: Labour induction at 39 weeks and 0 to 3 days of gestation
Number of subjects: 1900
Study 35470194 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (waiting for spontaneous labour onset or induction if medically indicated)
Number of subjects: 1900
Study 34022051 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg daily
Number of subjects: 26
Study 34022051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 34098291 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 94
Study 34098291 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 94
Study 35675498 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive sliding scale insulin (correction for BG >140 mg/dL)
Number of subjects: 215
Study 35675498 — intervention group
Group type: COMPARATOR
Intervention: Nonintensive sliding scale insulin (correction for BG >260 mg/dL)
Number of subjects: 215
Study 35675498 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive sliding scale insulin
Number of subjects: 215
Study 35675498 — intervention group
Group type: COMPARATOR
Intervention: Nonintensive sliding scale insulin
Number of subjects: 215
Study 33938259 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported adherence
Number of subjects: 214
Study 33938259 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitored adherence
Number of subjects: 214
Study 33938259 — intervention group
Group type: COMPARATOR
Intervention: Exposure-based adherence
Number of subjects: 214
Study 32902387 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted care pathway (n=37) using a social robot conducting a 36-item PROM
Number of subjects: 75
Study 32902387 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=38) using professional interviews
Number of subjects: 75
Study 32902387 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers in the robot-assisted care pathway (n=30)
Number of subjects: 75
Study 32902387 — intervention group
Group type: COMPARATOR
Intervention: Caregivers in the control group (n=35)
Number of subjects: 75
Study 35902705 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplements
Number of subjects: 24
Study 35902705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 34976760 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam with intranasal S-ketamine
Number of subjects: 80
Study 34976760 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam
Number of subjects: 80
Study 33059647 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-interventional program including mechanical bowel preparation with oral antibiotics, tailored full splenic flexure mobilization, and intraoperative fluorescence angiography using indocyanine green.
Number of subjects: 488
Study 33059647 — intervention group
Group type: COMPARATOR
Intervention: Current local practice (control cohort).
Number of subjects: 488
Study 33059647 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-interventional program.
Number of subjects: 488
Study 36011647 — intervention group
Group type: EXPERIMENTAL
Intervention: I1 (pedometer and goal of 10,000 steps/day)
Number of subjects: 270
Study 36011647 — intervention group
Group type: EXPERIMENTAL
Intervention: I2 (pedometer without a goal)
Number of subjects: 270
Study 36011647 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 270
Study 36011647 — intervention group
Group type: EXPERIMENTAL
Intervention: I1 and I2
Number of subjects: 270
Study 32702701 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic lithotripsy (group A)
Number of subjects: 50
Study 32702701 — intervention group
Group type: COMPARATOR
Intervention: Ho:YAG laser lithotripsy (group B)
Number of subjects: 50
Study 35340337 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of lidocaine (Group L)
Number of subjects: 99
Study 35340337 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided transverse abdominal plane block (Group T)
Number of subjects: 99
Study 35340337 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 99
Study 33476177 — intervention group
Group type: EXPERIMENTAL
Intervention: iOS app support
Number of subjects: 34
Study 33476177 — intervention group
Group type: COMPARATOR
Intervention: Written homework instructions
Number of subjects: 34
Study 35835822 — intervention group
Group type: EXPERIMENTAL
Intervention: Third dose of BBV152 (COVAXIN®)
Number of subjects: 0
Study 35835822 — intervention group
Group type: COMPARATOR
Intervention: Two doses of BBV152 (COVAXIN®)
Number of subjects: 0
Study 34933950 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus general care (HGC)
Number of subjects: 150
Study 34933950 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine plus general care (CGC)
Number of subjects: 150
Study 34933950 — intervention group
Group type: COMPARATOR
Intervention: Only general care (OGC)
Number of subjects: 150
Study 35176913 — intervention group
Group type: EXPERIMENTAL
Intervention: Advocacy education curriculum
Number of subjects: 80
Study 35176913 — intervention group
Group type: COMPARATOR
Intervention: Control group (no advocacy education)
Number of subjects: 80
Study 33581715 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle and risk factor modification intervention programme
Number of subjects: 0
Study 33581715 — intervention group
Group type: COMPARATOR
Intervention: Standard healthcare
Number of subjects: 0
Study 34995522 — intervention group
Group type: EXPERIMENTAL
Intervention: IOL repositioning by scleral suturing
Number of subjects: 100
Study 34995522 — intervention group
Group type: COMPARATOR
Intervention: IOL exchange with retropupillary fixation of an iris-claw lens
Number of subjects: 100
Study 33915091 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic pancreatoduodenectomy (LPD)
Number of subjects: 656
Study 33915091 — intervention group
Group type: COMPARATOR
Intervention: Open pancreatoduodenectomy (OPD)
Number of subjects: 656
Study 35584181 — intervention group
Group type: EXPERIMENTAL
Intervention: MOSAIC Plus intervention
Number of subjects: 40
Study 35584181 — intervention group
Group type: COMPARATOR
Intervention: Traditional MOSAIC intervention
Number of subjects: 40
Study 33148725 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentive (shopping points)
Number of subjects: 72
Study 33148725 — intervention group
Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 72
Study 33683617 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care + virtual reality
Number of subjects: 63
Study 33683617 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 63
Study 32213443 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) concentration in Peripheral Blood Mononuclear Cells (Cu.PBMC)
Number of subjects: 70
Study 32213443 — intervention group
Group type: COMPARATOR
Intervention: Levetiracetam (LEV) concentration in serum (Cu.serum)
Number of subjects: 70
Study 36064489 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary treatments including psychology, physiotherapy, and medical interventions for up to 12 weeks
Number of subjects: 15
Study 32222056 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin pump education curriculum
Number of subjects: 64
Study 32222056 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitor (CGM) education curriculum
Number of subjects: 64
Study 35759843 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade III lumbar rotational mobilization
Number of subjects: 42
Study 35759843 — intervention group
Group type: COMPARATOR
Intervention: Grade I lumbar rotational mobilization (Control)
Number of subjects: 42
Study 33640008 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model for predicting flare probability after tapering bDMARDs
Number of subjects: 41
Study 33640008 — intervention group
Group type: EXPERIMENTAL
Intervention: Percent dose change of bDMARDs
Number of subjects: 41
Study 33640008 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical disease activity (DAS-28 ESR)
Number of subjects: 41
Study 33640008 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease duration
Number of subjects: 41
Study 33640008 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammatory markers
Number of subjects: 41
Study 33106259 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion (CON) of fosfomycin at 1 g/h preceded by a loading dose of 8 g over 30 min
Number of subjects: 8
Study 33106259 — intervention group
Group type: COMPARATOR
Intervention: Intermittent infusion (INT) of fosfomycin at 8 g over 30 min every 8 h
Number of subjects: 8
Study 34305239 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS), 10 sessions, 20 minutes each, anode at F3, cathode at F4, current intensity 1.5 mA
Number of subjects: 30
Study 34305239 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 33361166 — intervention group
Group type: EXPERIMENTAL
Intervention: InnoSEAL + TRB
Number of subjects: 714
Study 33361166 — intervention group
Group type: COMPARATOR
Intervention: TRB alone
Number of subjects: 714
Study 33307226 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAPT+ (multi-family behavioral obesity intervention with mindfulness strategies)
Number of subjects: 0
Study 33307226 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 0
Study 32383366 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus pentosus (1.0 × 10^10 CFU daily for 12 weeks)
Number of subjects: 82
Study 32383366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 32383366 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus pentosus
Number of subjects: 82
Study 35869497 — intervention group
Group type: EXPERIMENTAL
Intervention: NeuroSAFE robotic-assisted radical prostatectomy (RARP)
Number of subjects: 404
Study 35869497 — intervention group
Group type: COMPARATOR
Intervention: Standard robotic-assisted radical prostatectomy (RARP)
Number of subjects: 404
Study 32143652 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous timed AVAPS (ST/AVAPS)
Number of subjects: 40
Study 32143652 — intervention group
Group type: COMPARATOR
Intervention: Bilevel positive airway pressure (ST/BiPAP)
Number of subjects: 40
Study 33905011 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraoral photobiomodulation (EOPBM)
Number of subjects: 60
Study 33905011 — intervention group
Group type: COMPARATOR
Intervention: Intraoral photobiomodulation (IOPBM)
Number of subjects: 60
Study 32359046 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-serving edible
Number of subjects: 26894
Study 32359046 — intervention group
Group type: EXPERIMENTAL
Intervention: Unit-dose packaging
Number of subjects: 26894
Study 32359046 — intervention group
Group type: COMPARATOR
Intervention: Multiserving edible (control condition)
Number of subjects: 26894
Study 34952751 — intervention group
Group type: EXPERIMENTAL
Intervention: ccIIV4
Number of subjects: 198
Study 34952751 — intervention group
Group type: EXPERIMENTAL
Intervention: LAIV4
Number of subjects: 198
Study 32387453 — intervention group
Group type: EXPERIMENTAL
Intervention: irinotecan/panitumumab (IrPan)
Number of subjects: 1180
Study 32387453 — intervention group
Group type: COMPARATOR
Intervention: irinotecan
Number of subjects: 1180
Study 36803399 — intervention group
Group type: EXPERIMENTAL
Intervention: Overground walking with paretic lower limb loading
Number of subjects: 48
Study 36803399 — intervention group
Group type: COMPARATOR
Intervention: Overground walking without paretic lower limb loading
Number of subjects: 48
Study 34516429 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental unit waterlines with 5-15% sodium hypochlorite
Number of subjects: 82
Study 34516429 — intervention group
Group type: COMPARATOR
Intervention: Dental specialty
Number of subjects: 82
Study 34516429 — intervention group
Group type: COMPARATOR
Intervention: Time of sample collection
Number of subjects: 82
Study 34516429 — intervention group
Group type: COMPARATOR
Intervention: Older age of dental unit
Number of subjects: 82
Study 32160019 — intervention group
Group type: EXPERIMENTAL
Intervention: C12 (0.4 kcal/min)
Number of subjects: 16
Study 32160019 — intervention group
Group type: EXPERIMENTAL
Intervention: Leu (0.45 kcal/min)
Number of subjects: 16
Study 32160019 — intervention group
Group type: EXPERIMENTAL
Intervention: C12+Leu (0.85 kcal/min)
Number of subjects: 16
Study 35382772 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwifery-led counseling (six 60-90 min sessions, twice a week)
Number of subjects: 50
Study 35382772 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwifery-led counseling
Number of subjects: 50
Study 35382772 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 34166434 — intervention group
Group type: EXPERIMENTAL
Intervention: High academic performance
Number of subjects: 1287
Study 34166434 — intervention group
Group type: COMPARATOR
Intervention: Low academic performance (failing a subject or repeating a year)
Number of subjects: 1287
Study 34166434 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional intelligence (stress management and mood)
Number of subjects: 1287
Study 33238242 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate wrapping pressure
Number of subjects: 19
Study 33238242 — intervention group
Group type: COMPARATOR
Intervention: High wrapping pressure
Number of subjects: 19
Study 33238242 — intervention group
Group type: COMPARATOR
Intervention: Control (loose band application)
Number of subjects: 19
Study 35685654 — intervention group
Group type: EXPERIMENTAL
Intervention: iDose4 reconstruction algorithm, tube voltage 120 kV
Number of subjects: 90
Study 35685654 — intervention group
Group type: EXPERIMENTAL
Intervention: iDose4 reconstruction algorithm, tube voltage 100 kV
Number of subjects: 90
Study 35685654 — intervention group
Group type: COMPARATOR
Intervention: Filtered back projection (FBP) reconstruction algorithm, tube voltage 120 kV
Number of subjects: 90
Study 33653354 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-shifting asthma education intervention delivered by lay-educators
Number of subjects: 43
Study 33653354 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-intervention training and support for lay-educators
Number of subjects: 43
Study 33653354 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenges faced by participants prior to the intervention
Number of subjects: 43
Study 35701094 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumen-apposing metal stents (LAMS)
Number of subjects: 53
Study 35701094 — intervention group
Group type: COMPARATOR
Intervention: Double-pigtail plastic stents
Number of subjects: 53
Study 33692191 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention to implement guideline recommendations for low back pain care
Number of subjects: 4491
Study 35899345 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based self-management group intervention
Number of subjects: 500
Study 35899345 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 500
Study 33431510 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization studies
Number of subjects: 0
Study 33431510 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized trials
Number of subjects: 0
Study 34284845 — intervention group
Group type: EXPERIMENTAL
Intervention: Care-seeking for noncommunicable diseases
Number of subjects: 600
Study 34284845 — intervention group
Group type: EXPERIMENTAL
Intervention: Diarrhea in children
Number of subjects: 600
Study 34284845 — intervention group
Group type: EXPERIMENTAL
Intervention: Cough/difficulty breathing
Number of subjects: 600
Study 34284845 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy complications
Number of subjects: 600
Study 34284845 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional and psychological complaints
Number of subjects: 600
Study 34492306 — intervention group
Group type: EXPERIMENTAL
Intervention: iSIPsmarter intervention
Number of subjects: 244
Study 34492306 — intervention group
Group type: COMPARATOR
Intervention: static Participant Education website
Number of subjects: 244
Study 34343968 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA (Patient-Controlled Analgesia)
Number of subjects: 214
Study 34343968 — intervention group
Group type: COMPARATOR
Intervention: non-PCA (Hydromorphone Titration by Healthcare Provider)
Number of subjects: 214
Study 34343968 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA
Number of subjects: 214
Study 34343968 — intervention group
Group type: COMPARATOR
Intervention: non-PCA
Number of subjects: 214
Study 32171086 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-learning computer-aided detection system (CADe)
Number of subjects: 0
Study 32171086 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard colonoscopy without CADe)
Number of subjects: 0
Study 35770339 — intervention group
Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) imaging system during video-assisted thoracoscopic surgery radical esophagectomy
Number of subjects: 40
Study 35770339 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard procedure without ICG)
Number of subjects: 40
Study 34471087 — intervention group
Group type: EXPERIMENTAL
Intervention: Danhong injection (DHI) for 14 days
Number of subjects: 920
Study 34471087 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 920
Study 32521115 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture ligation with suspension
Number of subjects: 300
Study 32521115 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic stapling
Number of subjects: 300
Study 32521115 — intervention group
Group type: COMPARATOR
Intervention: Cut and suture ligation
Number of subjects: 300
Study 32521115 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve sparing
Number of subjects: 300
Study 32521115 — intervention group
Group type: COMPARATOR
Intervention: Non-nerve sparing
Number of subjects: 300
Study 35198639 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol
Number of subjects: 170
Study 35198639 — intervention group
Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 170
Study 32210467 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent food frequency questionnaire (FFQ)
Number of subjects: 590
Study 34174082 — intervention group
Group type: COMPARATOR
Intervention: Neutralizing antibody (nAb) titers
Number of subjects: 0
Study 34052249 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE) - 45-min treadmill run at 60% VO2max
Number of subjects: 12